AP NEWS
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Bristol-Myers Squibb to Announce Results for First Quarter 2019 on April 25, 2019

March 7, 2019

NEW YORK--(BUSINESS WIRE)--Mar 7, 2019--Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the first quarter of 2019 on Thursday, April 25, 2019. During a conference call at 10:30 a.m. ET on April 25, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 888-254-3590 or international 720-543-0302, confirmation code: 7211894. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:45 p.m. ET on April 25 through 1:45 p.m. ET on May 9, 2019. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-254-3590 or international 720-543-0302, confirmation code: 7211894.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at  BMS.com  or follow us on LinkedInTwitter, YouTube and Facebook.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190307005122/en/

CONTACT: Bristol-Myers Squibb Company

Media: Carrie Fernandez, 609-252-5222,carrie.fernandez@bms.com

Investors: John Elicker, 609-252-4611,john.elicker@bms.com, Tim Power 609-252-7509timothy.power@bms.com

KEYWORD: UNITED STATES NORTH AMERICA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Bristol-Myers Squibb Company

Copyright Business Wire 2019.

PUB: 03/07/2019 06:59 AM/DISC: 03/07/2019 06:59 AM

http://www.businesswire.com/news/home/20190307005122/en